Vaccination against Lyme disease caused by diverse Borrelia burgdorferi

Erol Fikrig, Sam R. Telford, Reinhard Wallich, Manchuan Chen, Yves Lobet, Franz R. Matuschka, Robert B. Kimsey, Fred S. Kantor, Stephen W Barthold, Andrew Spielman, Richard A. Flavell

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Diversity and mutations in the genes for outer surface proteins (Osps) A and B of Borrelia burgdorferi sensu lato (B. burgdorferi), the spirochetal agent of Lyme disease, suggests that a monovalent OspA or OspB vaccine may not provide protection against antigenically variable naturally occurring B burgdorferi. We now show that OspA or OspB immunizations protect mice from tick-borne infection with heterogeneous B. burgdorferi from different geographic regions. This result is in distinct contrast to in vitro killing analyses and in vivo protection studies using syringe injections of B. burgdorferi as the challenge inoculum. Evaluations of vaccine efficacy against Lyme disease and other vector-borne infections should use the natural mode of transmission and not be predicated on classification systems or assays that do not rely upon the vector to transmit infection.

Original languageEnglish (US)
Pages (from-to)215-221
Number of pages7
JournalJournal of Experimental Medicine
Volume181
Issue number1
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Borrelia burgdorferi Group
Borrelia burgdorferi
Lyme Disease
Vaccination
Vaccines
Tick-Borne Diseases
Disease Vectors
Syringes
Infection
Immunization
Mutation
Injections
Genes

ASJC Scopus subject areas

  • Immunology

Cite this

Fikrig, E., Telford, S. R., Wallich, R., Chen, M., Lobet, Y., Matuschka, F. R., ... Flavell, R. A. (1995). Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. Journal of Experimental Medicine, 181(1), 215-221. https://doi.org/10.1084/jem.181.1.215

Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. / Fikrig, Erol; Telford, Sam R.; Wallich, Reinhard; Chen, Manchuan; Lobet, Yves; Matuschka, Franz R.; Kimsey, Robert B.; Kantor, Fred S.; Barthold, Stephen W; Spielman, Andrew; Flavell, Richard A.

In: Journal of Experimental Medicine, Vol. 181, No. 1, 01.01.1995, p. 215-221.

Research output: Contribution to journalArticle

Fikrig, E, Telford, SR, Wallich, R, Chen, M, Lobet, Y, Matuschka, FR, Kimsey, RB, Kantor, FS, Barthold, SW, Spielman, A & Flavell, RA 1995, 'Vaccination against Lyme disease caused by diverse Borrelia burgdorferi', Journal of Experimental Medicine, vol. 181, no. 1, pp. 215-221. https://doi.org/10.1084/jem.181.1.215
Fikrig E, Telford SR, Wallich R, Chen M, Lobet Y, Matuschka FR et al. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. Journal of Experimental Medicine. 1995 Jan 1;181(1):215-221. https://doi.org/10.1084/jem.181.1.215
Fikrig, Erol ; Telford, Sam R. ; Wallich, Reinhard ; Chen, Manchuan ; Lobet, Yves ; Matuschka, Franz R. ; Kimsey, Robert B. ; Kantor, Fred S. ; Barthold, Stephen W ; Spielman, Andrew ; Flavell, Richard A. / Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. In: Journal of Experimental Medicine. 1995 ; Vol. 181, No. 1. pp. 215-221.
@article{695b6f23c2ca45f9b2ef5d134c655117,
title = "Vaccination against Lyme disease caused by diverse Borrelia burgdorferi",
abstract = "Diversity and mutations in the genes for outer surface proteins (Osps) A and B of Borrelia burgdorferi sensu lato (B. burgdorferi), the spirochetal agent of Lyme disease, suggests that a monovalent OspA or OspB vaccine may not provide protection against antigenically variable naturally occurring B burgdorferi. We now show that OspA or OspB immunizations protect mice from tick-borne infection with heterogeneous B. burgdorferi from different geographic regions. This result is in distinct contrast to in vitro killing analyses and in vivo protection studies using syringe injections of B. burgdorferi as the challenge inoculum. Evaluations of vaccine efficacy against Lyme disease and other vector-borne infections should use the natural mode of transmission and not be predicated on classification systems or assays that do not rely upon the vector to transmit infection.",
author = "Erol Fikrig and Telford, {Sam R.} and Reinhard Wallich and Manchuan Chen and Yves Lobet and Matuschka, {Franz R.} and Kimsey, {Robert B.} and Kantor, {Fred S.} and Barthold, {Stephen W} and Andrew Spielman and Flavell, {Richard A.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1084/jem.181.1.215",
language = "English (US)",
volume = "181",
pages = "215--221",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "1",

}

TY - JOUR

T1 - Vaccination against Lyme disease caused by diverse Borrelia burgdorferi

AU - Fikrig, Erol

AU - Telford, Sam R.

AU - Wallich, Reinhard

AU - Chen, Manchuan

AU - Lobet, Yves

AU - Matuschka, Franz R.

AU - Kimsey, Robert B.

AU - Kantor, Fred S.

AU - Barthold, Stephen W

AU - Spielman, Andrew

AU - Flavell, Richard A.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Diversity and mutations in the genes for outer surface proteins (Osps) A and B of Borrelia burgdorferi sensu lato (B. burgdorferi), the spirochetal agent of Lyme disease, suggests that a monovalent OspA or OspB vaccine may not provide protection against antigenically variable naturally occurring B burgdorferi. We now show that OspA or OspB immunizations protect mice from tick-borne infection with heterogeneous B. burgdorferi from different geographic regions. This result is in distinct contrast to in vitro killing analyses and in vivo protection studies using syringe injections of B. burgdorferi as the challenge inoculum. Evaluations of vaccine efficacy against Lyme disease and other vector-borne infections should use the natural mode of transmission and not be predicated on classification systems or assays that do not rely upon the vector to transmit infection.

AB - Diversity and mutations in the genes for outer surface proteins (Osps) A and B of Borrelia burgdorferi sensu lato (B. burgdorferi), the spirochetal agent of Lyme disease, suggests that a monovalent OspA or OspB vaccine may not provide protection against antigenically variable naturally occurring B burgdorferi. We now show that OspA or OspB immunizations protect mice from tick-borne infection with heterogeneous B. burgdorferi from different geographic regions. This result is in distinct contrast to in vitro killing analyses and in vivo protection studies using syringe injections of B. burgdorferi as the challenge inoculum. Evaluations of vaccine efficacy against Lyme disease and other vector-borne infections should use the natural mode of transmission and not be predicated on classification systems or assays that do not rely upon the vector to transmit infection.

UR - http://www.scopus.com/inward/record.url?scp=0028966088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028966088&partnerID=8YFLogxK

U2 - 10.1084/jem.181.1.215

DO - 10.1084/jem.181.1.215

M3 - Article

C2 - 7807004

AN - SCOPUS:0028966088

VL - 181

SP - 215

EP - 221

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 1

ER -